Open Access

Effects of intranasal administration with Bacillus subtilis on immune cells in the nasal mucosa and tonsils of piglets

  • Authors:
    • Yunhan Yang
    • Yuchao Jing
    • Jingjing Yang
    • Qian Yang
  • View Affiliations

  • Published online on: April 24, 2018     https://doi.org/10.3892/etm.2018.6093
  • Pages: 5189-5198
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The nasal mucosa is the body's first barrier against pathogens entering through the respiratory tract. The respiratory immune system of pigs has more similarities with humans than the mouse respiratory system does, and so was selected as the animal model in the present study. To evaluate the effects of Bacillus subtilis as a potential probiotic to stimulate local immune responses, piglets were intranasally administered with Dylight 488‑labeled B. subtilis (WB800‑green fluorescent protein). The results revealed that B. subtilis was able to reach the lamina propria of the nasal mucosa, nasopharyngeal tonsils and soft palate tonsils. Piglets were subsequently administered intranasally with B. subtilis (WB800) at 3, 12 and 28 days. The results revealed that, following administration with B. subtilis, the number of dendritic cells, immunoglobulin A+ B cells and T cells in the nasal mucosa and tonsils significantly increased (P<0.05). No obvious differences were observed in the morphological structure following B. subtilis administration. There were no statistical differences were observed in the expression of interleukin (IL)‑1β, tumor necrosis factor‑α and IL‑8 mRNA between the B. subtilis treated group and the control group in the nasal mucosa, nasopharyngeal tonsil or soft palate tonsil. Toll‑like receptor (TLR)‑2 and TLR‑9 mRNA expression in the tonsils was significantly increased following B. subtilis administration compared with the control group (P<0.05). The results demonstrate that B. subtilis administration increases the number of immune cells in the nasal mucosa and tonsils of piglets and stimulates nasal mucosal and tonsillar immunity. The present study lays the foundation for further study into the intranasal administration of B. subtilis in humans to enhance the immunity of human nasal mucosa to respiratory diseases.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 15 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang Y, Jing Y, Yang J and Yang Q: Effects of intranasal administration with Bacillus subtilis on immune cells in the nasal mucosa and tonsils of piglets. Exp Ther Med 15: 5189-5198, 2018
APA
Yang, Y., Jing, Y., Yang, J., & Yang, Q. (2018). Effects of intranasal administration with Bacillus subtilis on immune cells in the nasal mucosa and tonsils of piglets. Experimental and Therapeutic Medicine, 15, 5189-5198. https://doi.org/10.3892/etm.2018.6093
MLA
Yang, Y., Jing, Y., Yang, J., Yang, Q."Effects of intranasal administration with Bacillus subtilis on immune cells in the nasal mucosa and tonsils of piglets". Experimental and Therapeutic Medicine 15.6 (2018): 5189-5198.
Chicago
Yang, Y., Jing, Y., Yang, J., Yang, Q."Effects of intranasal administration with Bacillus subtilis on immune cells in the nasal mucosa and tonsils of piglets". Experimental and Therapeutic Medicine 15, no. 6 (2018): 5189-5198. https://doi.org/10.3892/etm.2018.6093